Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Joshua Korzenik, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Ho SM, Lewis JD, Mayer EA, Plevy SE, Chuang E, Rappaport SM, Croitoru K, Korzenik JR, Krischer J, Hyams JS, Judson R, Kellis M, Jerrett M, Miller GW, Grant ML, Shtraizent N, Honig G, Hurtado-Lorenzo A, Wu GD. Challenges in IBD Research: Environmental Triggers. Inflamm Bowel Dis. 2019 May 16; 25(Supplement_2):S13-S23. PMID: 31095702.
    Citations:    
  2. Korzenik J. Don't Worry, Be Happy: Psychological Interventions in Inflammatory Bowel Disease. Gastroenterology. 2019 03; 156(4):856-857. PMID: 30776343.
    Citations:    
  3. Allegretti JR, Kassam Z, Carrellas M, Mullish BH, Marchesi JR, Pechlivanis A, Smith M, Gerardin Y, Timberlake S, Pratt DS, Korzenik JR. Fecal Microbiota Transplantation in Patients With Primary Sclerosing Cholangitis: A Pilot Clinical Trial. Am J Gastroenterol. 2019 Jan 31. PMID: 30730351.
    Citations:    
  4. Ouahed J, Gordon W, Canavan JB, Zhou H, Du S, von Schack D, Phillips K, Wang L, Dunn WA, Field M, Friel S, Griffith A, Evans S, Tollefson S, Carrellas M, Cao B, Merker A, Bousvaros A, Shouval DS, Hung K, Lepsy C, Afzelius L, Korzenik JR, Snapper SB. Mucosal Gene Expression in Pediatric and Adult Patients With Ulcerative Colitis Permits Modeling of Ideal Biopsy Collection Strategy for Transcriptomic Analysis. Inflamm Bowel Dis. 2018 11 29; 24(12):2565-2578. PMID: 30085215.
    Citations:    Fields:    
  5. de Silva PS, O'Toole A, Marc LG, Ulysse CA, Testa MA, Julsgaard M, Ngyuen D, Ananthakrishnan A, Laursen T, Højgaard A, Christensen LA, Korzenik J, Friedman S. Development of a Sexual Dysfunction Scale for Women With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 10 12; 24(11):2350-2359. PMID: 30165525.
    Citations:    Fields:    
  6. Merker AM, Riaz M, Friedman S, Allegretti JR, Korzenik J. Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 10 12; 24(11):2309-2314. PMID: 29788102.
    Citations:    Fields:    
  7. Nassan FL, Korevaar TIM, Coull BA, Skakkebæk NE, Krawetz SA, Estill M, Hait EJ, Korzenik JR, Ford JB, De Poortere RA, Broeren MA, Moss AC, Zoeller TR, Hauser R. Dibutyl-phthalate exposure from mesalamine medications and serum thyroid hormones in men. Int J Hyg Environ Health. 2019 Jan; 222(1):101-110. PMID: 30170956.
    Citations:    Fields:    
  8. Han L, Maciejewski M, Brockel C, Gordon W, Snapper SB, Korzenik JR, Afzelius L, Altman RB. A probabilistic pathway score (PROPS) for classification with applications to inflammatory bowel disease. Bioinformatics. 2018 03 15; 34(6):985-993. PMID: 29048458.
    Citations:    Fields:    Translation:Humans
  9. O'Toole A, de Silva PS, Marc LG, Ulysse CA, Testa MA, Ting A, Moss A, Korzenik J, Friedman S. Sexual Dysfunction in Men With Inflammatory Bowel Disease: A New IBD-Specific Scale. Inflamm Bowel Dis. 2018 01 18; 24(2):310-316. PMID: 29361102.
    Citations:    Fields:    
  10. Marchioni Beery RM, Barnes EL, Nadkarni A, Korzenik JR. Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis. Inflamm Bowel Dis. 2017 12 19; 24(1):25-34. PMID: 29272476.
    Citations:    Fields:    
  11. Winter RW, Korzenik JR. The Practical Pros and Cons of Complementary and Alternative Medicine in Practice: Integrating Complementary and Alternative Medicine into Clinical Care. Gastroenterol Clin North Am. 2017 12; 46(4):907-916. PMID: 29173531.
    Citations:    Fields:    Translation:Humans
  12. Barnes EL, Kochar B, Long MD, Martin CF, Crockett SD, Korzenik JR, Kappelman MD. The Burden of Hospital Readmissions among Pediatric Patients with Inflammatory Bowel Disease. J Pediatr. 2017 12; 191:184-189.e1. PMID: 29037795.
    Citations:    
  13. de Silva PS, Yang X, Korzenik JR, Goldman RH, Arheart KL, Caban-Martinez AJ. Association of urinary phenolic compounds, inflammatory bowel disease and chronic diarrheal symptoms: Evidence from the National Health and Nutrition Examination Survey. Environ Pollut. 2017 Oct; 229:621-626. PMID: 28689150.
    Citations:    Fields:    Translation:HumansPHPublic Health
  14. Nassan FL, Coull BA, Skakkebaek NE, Andersson AM, Williams MA, Mínguez-Alarcón L, Krawetz SA, Hall JE, Hait EJ, Korzenik JR, Ford JB, Moss AC, Hauser R. A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and serum reproductive hormones in men. Environ Res. 2018 01; 160:121-131. PMID: 28978458.
    Citations: 2     Fields:    Translation:Humans
  15. Korzenik J, Koch AK, Langhorst J. Complementary and Integrative Gastroenterology. Med Clin North Am. 2017 Sep; 101(5):943-954. PMID: 28802472.
    Citations: 1     Fields:    Translation:Humans
  16. Barnes EL, Kochar B, Long MD, Kappelman MD, Martin CF, Korzenik JR, Crockett SD. Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database. Inflamm Bowel Dis. 2017 06; 23(6):875-881. PMID: 28426473.
    Citations: 3     Fields:    Translation:Humans
  17. Solomon DH, Shadick NA, Weinblatt ME, Frits M, Iannaccone C, Zak A, Korzenik JR. Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries. BMC Med Res Methodol. 2017 Apr 17; 17(1):59. PMID: 28415991.
    Citations:    Fields:    Translation:Humans
  18. Allegretti JR, Barnes EL, Stevens B, Storm M, Ananthakrishnan A, Yajnik V, Korzenik J. Predictors of Clinical Response and Remission at 1 Year Among a Multicenter Cohort of Patients with Inflammatory Bowel Disease Treated with Vedolizumab. Dig Dis Sci. 2017 06; 62(6):1590-1596. PMID: 28357697.
    Citations: 2     Fields:    Translation:Humans
  19. Kuo B, Bhasin M, Jacquart J, Scult MA, Slipp L, Riklin EI, Lepoutre V, Comosa N, Norton BA, Dassatti A, Rosenblum J, Thurler AH, Surjanhata BC, Hasheminejad NN, Kagan L, Slawsby E, Rao SR, Macklin EA, Fricchione GL, Benson H, Libermann TA, Korzenik J, Denninger JW. Correction: Genomic and Clinical Effects Associated with a Relaxation Response Mind-Body Intervention in Patients with Irritable Bowel Syndrome and Inflammatory Bowel Disease. PLoS One. 2017; 12(2):e0172872. PMID: 28222181.
    Citations:    Fields:    
  20. Goettel J, Kotlarz D, Illig D, Canavan J, Allegretti J, Hamilton M, Kelly R, Griffith A, Carellas M, Nelina A, Bousvaros A, Korzenik J, Snapper S. O-011 Low-dose IL-2 Administration Expands Human Regulatory T Cells in Patients with UC and Humanized Mice and Protects Against Experimental Colitis. Inflamm Bowel Dis. 2017 Feb; 23 Suppl 1:S4. PMID: 28125559.
    Citations:    
  21. Barnes EL, Nestor M, Onyewadume L, de Silva PS, Korzenik JR. High Dietary Intake of Specific Fatty Acids Increases Risk of Flares in Patients With Ulcerative Colitis in Remission During Treatment With Aminosalicylates. Clin Gastroenterol Hepatol. 2017 Sep; 15(9):1390-1396.e1. PMID: 28110099.
    Citations: 1     Fields:    Translation:Humans
  22. Winter RW, Collins E, Cao B, Carrellas M, Crowell AM, Korzenik JR. Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-a medications among patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2017 03; 45(5):653-659. PMID: 28074487.
    Citations: 1     Fields:    Translation:Humans
  23. Barnes EL, Goldin A, Winter RW, Collins E, Cao B, Carrellas M, Crowell AM, Korzenik JR. Sequential Combination Therapy Versus Monotherapy: A Lack of Benefit in Time to Inflammatory Bowel Disease-Related Surgery. Dig Dis Sci. 2016 11; 61(11):3261-3269. PMID: 27639871.
    Citations: 1     Fields:    Translation:Humans
  24. Barnes EL, Beery RM, Schulman AR, McCarthy EP, Korzenik JR, Winter RW. Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database. Inflamm Bowel Dis. 2016 09; 22(9):2229-37. PMID: 27542135.
    Citations: 3     Fields:    Translation:Humans
  25. Vaughn BP, Vatanen T, Allegretti JR, Bai A, Xavier RJ, Korzenik J, Gevers D, Ting A, Robson SC, Moss AC. Increased Intestinal Microbial Diversity Following Fecal Microbiota Transplant for Active Crohn's Disease. Inflamm Bowel Dis. 2016 09; 22(9):2182-90. PMID: 27542133.
    Citations: 18     Fields:    Translation:HumansCells
  26. Nassan FL, Coull BA, Skakkebaek NE, Williams MA, Dadd R, Mínguez-Alarcón L, Krawetz SA, Hait EJ, Korzenik JR, Moss AC, Ford JB, Hauser R. A crossover-crossback prospective study of dibutyl-phthalate exposure from mesalamine medications and semen quality in men with inflammatory bowel disease. Environ Int. 2016 Oct; 95:120-30. PMID: 27575365.
    Citations: 2     Fields:    Translation:Humans
  27. Marchioni Beery RM, Korzenik JR. Crohn's Cartography: Mapping Disease Patterns and Trajectories Using the Lémann Index-Are We Finding Our Way? J Clin Gastroenterol. 2016 07; 50(6):441-4. PMID: 27159423.
    Citations:    Fields:    Translation:Humans
  28. Allegretti JR, Kearney S, Li N, Bogart E, Bullock K, Gerber GK, Bry L, Clish CB, Alm E, Korzenik JR. Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. Aliment Pharmacol Ther. 2016 06; 43(11):1142-53. PMID: 27086647.
    Citations: 16     Fields:    Translation:HumansCells
  29. Lennerz JK, van der Sloot KWJ, Le LP, Batten JM, Han JY, Fan KC, Siegel CA, Srivastava A, Park DY, Chen JH, Sands BE, Korzenik JR, Odze RD, Dias-Santagata D, Borger DR, Khalili H, Iafrate AJ, Lauwers GY. Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer. Int J Colorectal Dis. 2016 05; 31(5):973-982. PMID: 27026089.
    Citations: 3     Fields:    Translation:HumansCells
  30. O'Toole A, Lucci M, Korzenik J. Inflammatory Bowel Disease Provoked by Etanercept: Report of 443 Possible Cases Combined from an IBD Referral Center and the FDA. Dig Dis Sci. 2016 06; 61(6):1772-4. PMID: 26728477.
    Citations: 7     Fields:    Translation:Humans
  31. Dossett ML, Korzenik JR, Baim M, Denninger JW, Mehta DH. A Case Report of Improvement in Crohn's Disease-related Symptoms Following Participation in a Comprehensive Mind-Body Program. Glob Adv Health Med. 2016 Jan; 5(1):122-5. PMID: 26937324.
    Citations: 1     
  32. Konijeti GG, Arora P, Boylan MR, Song Y, Huang S, Harrell F, Newton-Cheh C, O'Neill D, Korzenik J, Wang TJ, Chan AT. Vitamin D Supplementation Modulates T Cell-Mediated Immunity in Humans: Results from a Randomized Control Trial. J Clin Endocrinol Metab. 2016 Feb; 101(2):533-8. PMID: 26653112.
    Citations: 6     Fields:    Translation:HumansCells
  33. Shelton E, Allegretti JR, Stevens B, Lucci M, Khalili H, Nguyen DD, Sauk J, Giallourakis C, Garber J, Hamilton MJ, Tomczak M, Makrauer F, Burakoff RB, Levine J, de Silva P, Friedman S, Ananthakrishnan A, Korzenik JR, Yajnik V. Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort. Inflamm Bowel Dis. 2015 Dec; 21(12):2879-85. PMID: 26288002.
    Citations: 25     Fields:    Translation:Humans
  34. Allegretti JR, Borges L, Lucci M, Chang M, Cao B, Collins E, Vogel B, Arthur E, Emmons D, Korzenik JR. Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015 Nov; 21(11):2583-9. PMID: 26244647.
    Citations: 7     Fields:    Translation:Humans
  35. Zhang S, Ermann J, Succi MD, Zhou A, Hamilton MJ, Cao B, Korzenik JR, Glickman JN, Vemula PK, Glimcher LH, Traverso G, Langer R, Karp JM. An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease. Sci Transl Med. 2015 Aug 12; 7(300):300ra128. PMID: 26268315.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  36. Burakoff R, Pabby V, Onyewadume L, Odze R, Adackapara C, Wang W, Friedman S, Hamilton M, Korzenik J, Levine J, Makrauer F, Cheng C, Smith HC, Liew CC, Chao S. Blood-based biomarkers used to predict disease activity in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2015 May; 21(5):1132-40. PMID: 25895006.
    Citations: 3     Fields:    Translation:Humans
  37. Kuo B, Bhasin M, Jacquart J, Scult MA, Slipp L, Riklin EI, Lepoutre V, Comosa N, Norton BA, Dassatti A, Rosenblum J, Thurler AH, Surjanhata BC, Hasheminejad NN, Kagan L, Slawsby E, Rao SR, Macklin EA, Fricchione GL, Benson H, Libermann TA, Korzenik J, Denninger JW. Genomic and clinical effects associated with a relaxation response mind-body intervention in patients with irritable bowel syndrome and inflammatory bowel disease. PLoS One. 2015; 10(4):e0123861. PMID: 25927528.
    Citations: 13     Fields:    Translation:HumansCellsCTClinical Trials
  38. Juillerat P, Sokol H, Froehlich F, Yajnik V, Beaugerie L, Lucci M, Burnand B, Macpherson AJ, Cosnes J, Korzenik JR. Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort. Inflamm Bowel Dis. 2015 Jan; 21(1):60-70. PMID: 25517594.
    Citations: 3     Fields:    Translation:Humans
  39. Allegretti JR, Korzenik JR, Hamilton MJ. Fecal microbiota transplantation via colonoscopy for recurrent C. difficile Infection. J Vis Exp. 2014 Dec 08; (94). PMID: 25549239.
    Citations: 5     Fields:    Translation:HumansCells
  40. Sauk J, Nguyen D, Yajnik V, Khalili H, Konijeti G, Hodin R, Bordeianou L, Shellito P, Sylla P, Korzenik J, Friedman S, Ananthakrishnan AN. Natural history of perianal Crohn's disease after fecal diversion. Inflamm Bowel Dis. 2014 Dec; 20(12):2260-5. PMID: 25230164.
    Citations: 5     Fields:    Translation:Humans
  41. de Silva P, Korzenik J. The changing epidemiology of inflammatory bowel disease: identifying new high-risk populations. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):690-2. PMID: 25451560.
    Citations: 2     Fields:    Translation:Humans
  42. Langhorst J, Wulfert H, Lauche R, Klose P, Cramer H, Dobos GJ, Korzenik J. Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohns Colitis. 2015 Jan; 9(1):86-106. PMID: 25518050.
    Citations: 16     Fields:    Translation:Humans
  43. Meelu P, Marin R, Clish C, Zella G, Cox S, Yajnik V, Nguyen DD, Korzenik JR. Impaired innate immune function associated with fecal supernatant from Crohn's disease patients: insights into potential pathogenic role of the microbiome. Inflamm Bowel Dis. 2014 Jul; 20(7):1139-46. PMID: 24892965.
    Citations: 1     Fields:    Translation:HumansCells
  44. Fowler SA, Ananthakrishnan AN, Gardet A, Stevens CR, Korzenik JR, Sands BE, Daly MJ, Xavier RJ, Yajnik V. SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease. J Crohns Colitis. 2014 Aug; 8(8):845-51. PMID: 24461721.
    Citations: 10     Fields:    Translation:Humans
  45. O'Toole A, Korzenik J. Environmental triggers for IBD. Curr Gastroenterol Rep. 2014; 16(7):396. PMID: 25048010.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  46. Ravikoff Allegretti J, Courtwright A, Lucci M, Korzenik JR, Levine J. Marijuana use patterns among patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Dec; 19(13):2809-14. PMID: 24185313.
    Citations: 13     Fields:    Translation:HumansAnimals
  47. Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ. 2013 Nov 14; 347:f6633. PMID: 24231178.
    Citations: 23     Fields:    Translation:Humans
  48. Kelstrup AM, Juillerat P, Korzenik J. The accuracy of self-reported medical history: a preliminary analysis of the promise of internet-based research in Inflammatory Bowel Diseases. J Crohns Colitis. 2014 May; 8(5):349-56. PMID: 24183653.
    Citations: 3     Fields:    Translation:Humans
  49. Juillerat P, Wasan SK, Fowler SA, Friedman S, Pabby VK, Coukas JA, Barto AE, Pellish R, Germansky KA, Cheifetz AS, Korzenik JR, Farraye FA, Yajnik V. Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis. 2013 Oct; 19(11):2457-63. PMID: 23962896.
    Citations: 8     Fields:    Translation:Humans
  50. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 2013 Nov; 145(5):970-7. PMID: 23912083.
    Citations: 63     Fields:    Translation:Humans
  51. Knutson CG, Mangerich A, Zeng Y, Raczynski AR, Liberman RG, Kang P, Ye W, Prestwich EG, Lu K, Wishnok JS, Korzenik JR, Wogan GN, Fox JG, Dedon PC, Tannenbaum SR. Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A. 2013 Jun 25; 110(26):E2332-41. PMID: 23754421.
    Citations: 30     Fields:    Translation:HumansAnimalsCells
  52. Oxford EC, Nguyen DD, Sauk J, Korzenik JR, Yajnik V, Friedman S, Ananthakrishnan AN. Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases. Am J Gastroenterol. 2013 Jul; 108(7):1123-9. PMID: 23419379.
    Citations: 12     Fields:    Translation:Humans
  53. Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Feb; 19(2):309-15. PMID: 22605668.
    Citations: 23     Fields:    Translation:Humans
  54. Ananthakrishnan AN, Korzenik JR, Hur C. Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. Inflamm Bowel Dis. 2013 Jan; 19(1):37-44. PMID: 22416019.
    Citations: 11     Fields:    Translation:Humans
  55. de Silva PS, Nguyen DD, Sauk J, Korzenik J, Yajnik V, Ananthakrishnan AN. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease. Aliment Pharmacol Ther. 2012 Sep; 36(5):459-66. PMID: 22784296.
    Citations: 11     Fields:    Translation:Humans
  56. Papa E, Docktor M, Smillie C, Weber S, Preheim SP, Gevers D, Giannoukos G, Ciulla D, Tabbaa D, Ingram J, Schauer DB, Ward DV, Korzenik JR, Xavier RJ, Bousvaros A, Alm EJ. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One. 2012; 7(6):e39242. PMID: 22768065.
    Citations: 55     Fields:    Translation:Humans
  57. Juillerat P, Schneeweiss S, Cook EF, Ananthakrishnan AN, Mogun H, Korzenik JR. Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease. Aliment Pharmacol Ther. 2012 Aug; 36(3):239-47. PMID: 22670722.
    Citations: 4     Fields:    Translation:Humans
  58. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012 Apr 16; 13(9):R79. PMID: 23013615.
    Citations: 416     Fields:    Translation:HumansCells
  59. Ravikoff JE, Cole EB, Korzenik JR. Barriers to enrollment in inflammatory bowel disease randomized controlled trials: an investigation of patient perspectives. Inflamm Bowel Dis. 2012 Nov; 18(11):2092-8. PMID: 22241674.
    Citations: 4     Fields:    Translation:Humans
  60. Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012 Mar; 142(3):482-9. PMID: 22155183.
    Citations: 101     Fields:    Translation:Humans
  61. Tinsley A, Macklin EA, Korzenik JR, Sands BE. Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2011 Dec; 34(11-12):1328-36. PMID: 21999576.
    Citations: 7     Fields:    Translation:Humans
  62. Cullen G, Kroshinsky D, Cheifetz AS, Korzenik JR. Psoriasis associated with anti-tumour necrosis factor therapy in inflammatory bowel disease: a new series and a review of 120 cases from the literature. Aliment Pharmacol Ther. 2011 Dec; 34(11-12):1318-27. PMID: 21957906.
    Citations: 25     Fields:    Translation:Humans
  63. Ananthakrishnan AN, Hur C, Korzenik JR. Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci. 2012 Feb; 57(2):472-80. PMID: 21909990.
    Citations: 7     Fields:    Translation:Humans
  64. Ananthakrishnan AN, Hur C, Juillerat P, Korzenik JR. Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol. 2011 Nov; 106(11):2009-17. PMID: 21788991.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  65. Cullen G, Bader C, Korzenik JR, Sands BE. Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut. 2012 Mar; 61(3):385-91. PMID: 21757451.
    Citations: 17     Fields:    Translation:HumansCells
  66. Bordeianou L, Stein SL, Ho VP, Dursun A, Sands BE, Korzenik JR, Hodin RA. Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn's disease? Surgery. 2011 Jan; 149(1):72-8. PMID: 20434748.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  67. Subramanian S, Yajnik V, Sands BE, Cullen G, Korzenik JR. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Inflamm Bowel Dis. 2011 Jan; 17(1):99-104. PMID: 20629183.
    Citations: 8     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
  68. Gardet A, Benita Y, Li C, Sands BE, Ballester I, Stevens C, Korzenik JR, Rioux JD, Daly MJ, Xavier RJ, Podolsky DK. LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol. 2010 Nov 01; 185(9):5577-85. PMID: 20921534.
    Citations: 98     Fields:    Translation:HumansAnimalsCells
  69. Zella GC, Hait EJ, Glavan T, Gevers D, Ward DV, Kitts CL, Korzenik JR. Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis. 2011 May; 17(5):1092-100. PMID: 20845425.
    Citations: 18     Fields:    Translation:HumansCells
  70. Kaplan GG, Hubbard J, Korzenik J, Sands BE, Panaccione R, Ghosh S, Wheeler AJ, Villeneuve PJ. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol. 2010 Nov; 105(11):2412-9. PMID: 20588264.
    Citations: 40     Fields:    Translation:HumansPHPublic Health
  71. Surolia I, Pirnie SP, Chellappa V, Taylor KN, Cariappa A, Moya J, Liu H, Bell DW, Driscoll DR, Diederichs S, Haider K, Netravali I, Le S, Elia R, Dow E, Lee A, Freudenberg J, De Jager PL, Chretien Y, Varki A, MacDonald ME, Gillis T, Behrens TW, Bloch D, Collier D, Korzenik J, Podolsky DK, Hafler D, Murali M, Sands B, Stone JH, Gregersen PK, Pillai S. Functionally defective germline variants of sialic acid acetylesterase in autoimmunity. Nature. 2010 Jul 08; 466(7303):243-7. PMID: 20555325.
    Citations: 59     Fields:    Translation:HumansAnimalsCells
  72. Sandborn WJ, Korzenik J, Lashner B, Leighton JA, Mahadevan U, Marion JF, Safdi M, Sninsky CA, Patel RM, Friedenberg KA, Dunnmon P, Ramsey D, Kane S. Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis. Gastroenterology. 2010 Apr; 138(4):1286-96, 1296.e1-3. PMID: 20064514.
    Citations: 18     Fields:    Translation:Humans
  73. Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, White RI, Young LH, Zarrabeitia R. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011 Feb; 48(2):73-87. PMID: 19553198.
    Citations: 120     Fields:    Translation:Humans
  74. Schneeweiss S, Korzenik J, Solomon DH, Canning C, Lee J, Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther. 2009 Aug; 30(3):253-64. PMID: 19438424.
    Citations: 51     Fields:    Translation:Humans
  75. Engelbrektson A, Korzenik JR, Pittler A, Sanders ME, Klaenhammer TR, Leyer G, Kitts CL. Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol. 2009 May; 58(Pt 5):663-70. PMID: 19369530.
    Citations: 15     Fields:    Translation:HumansCells
  76. Lam MY, Lee H, Bright R, Korzenik JR, Sands BE. Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire. Inflamm Bowel Dis. 2009 Apr; 15(4):599-607. PMID: 19023897.
    Citations: 8     Fields:    Translation:Humans
  77. Hait EJ, Barendse RM, Arnold JH, Valim C, Sands BE, Korzenik JR, Fishman LN. Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr. 2009 Jan; 48(1):61-5. PMID: 19172125.
    Citations: 26     Fields:    Translation:Humans
  78. Korzenik JR. Diverticulitis: new frontiers for an old country: risk factors and pathogenesis. J Clin Gastroenterol. 2008 Nov-Dec; 42(10):1128-9. PMID: 18936649.
    Citations: 4     Fields:    Translation:Humans
  79. Korzenik JR. Flare factor: are there any triggering factors associated with onset of clinical symptoms or disease relapse? Inflamm Bowel Dis. 2008 Oct; 14 Suppl 2:S150-1. PMID: 18816722.
    Citations:    Fields:    Translation:Humans
  80. Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J. The risk of developing Crohn's disease after an appendectomy: a meta-analysis. Am J Gastroenterol. 2008 Nov; 103(11):2925-31. PMID: 18775018.
    Citations: 29     Fields:    Translation:Humans
  81. Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg. 2008 Oct; 12(10):1730-6; discussion 1736-7. PMID: 18709514.
    Citations: 43     Fields:    Translation:Humans
  82. Kaplan GG, McCarthy EP, Ayanian JZ, Korzenik J, Hodin R, Sands BE. Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis. Gastroenterology. 2008 Mar; 134(3):680-7. PMID: 18242604.
    Citations: 54     Fields:    Translation:Humans
  83. Kaplan GG, Hur C, Korzenik J, Sands BE. Infliximab dose escalation vs. initiation of adalimumab for loss of response in Crohn's disease: a cost-effectiveness analysis. Aliment Pharmacol Ther. 2007 Dec; 26(11-12):1509-20. PMID: 17931345.
    Citations: 16     Fields:    Translation:Humans
  84. Kaplan GG, Pedersen BV, Andersson RE, Sands BE, Korzenik J, Frisch M. The risk of developing Crohn's disease after an appendectomy: a population-based cohort study in Sweden and Denmark. Gut. 2007 Oct; 56(10):1387-92. PMID: 17494106.
    Citations: 16     Fields:    Translation:Humans
  85. Korzenik J. The role of innate immunity in Crohn's disease. Gastroenterol Hepatol (N Y). 2007 Feb; 3(2):82-3. PMID: 21960814.
    Citations:    
  86. Korzenik JR. Is Crohn's disease due to defective immunity? Gut. 2007 Jan; 56(1):2-5. PMID: 17172582.
    Citations: 24     Fields:    Translation:HumansCells
  87. Bishnupuri KS, Luo Q, Korzenik JR, Henderson JO, Houchen CW, Anant S, Dieckgraefe BK. Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes. Cancer Biol Ther. 2006 Dec; 5(12):1714-20. PMID: 17106246.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  88. Yamamoto-Furusho JK, Korzenik JR. Crohn's disease: innate immunodeficiency? World J Gastroenterol. 2006 Nov 14; 12(42):6751-5. PMID: 17106921.
    Citations: 9     Fields:    Translation:HumansCells
  89. Korzenik JR. Case closed? Diverticulitis: epidemiology and fiber. J Clin Gastroenterol. 2006 Aug; 40 Suppl 3:S112-6. PMID: 16885692.
    Citations: 18     Fields:    Translation:Humans
  90. Engelbrektson AL, Korzenik JR, Sanders ME, Clement BG, Leyer G, Klaenhammer TR, Kitts CL. Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol. 2006 Aug; 57(2):239-50. PMID: 16867142.
    Citations: 13     Fields:    Translation:HumansCells
  91. Dieckgraefe BK, Korzenik JR, Anant S. Growth factors as treatment options for intestinal inflammation. Ann N Y Acad Sci. 2006 Aug; 1072:300-6. PMID: 17057209.
    Citations: 6     Fields:    Translation:Animals
  92. Siegel CA, Hur C, Korzenik JR, Gazelle GS, Sands BE. Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol. 2006 Aug; 4(8):1017-24; quiz 976. PMID: 16843733.
    Citations: 24     Fields:    Translation:Humans
  93. Kradin RL, Badizadegan K, Auluck P, Korzenik J, Lauwers GY. Iatrogenic Trichuris suis infection in a patient with Crohn disease. Arch Pathol Lab Med. 2006 May; 130(5):718-20. PMID: 16683891.
    Citations: 15     Fields:    Translation:HumansAnimalsCells
  94. Korzenik JR, Podolsky DK. Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov. 2006 Mar; 5(3):197-209. PMID: 16518373.
    Citations: 31     Fields:    Translation:HumansAnimalsCells
  95. Korzenik JR, Podolsky DK. Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2006 Feb; 4(2):157-9. PMID: 16469674.
    Citations: 4     Fields:    Translation:Humans
  96. Korzenik J, Chung DC, Digumarthy S, Badizadegan K. Case records of the Massachusetts General Hospital. Case 33-2005. A 43-year-old man with lower gastrointestinal bleeding. N Engl J Med. 2005 Oct 27; 353(17):1836-44. PMID: 16251540.
    Citations: 1     Fields:    Translation:Humans
  97. Lawrence SJ, Korzenik JR, Mundy LM. Probiotics for recurrent Clostridium difficile disease. J Med Microbiol. 2005 Sep; 54(Pt 9):905-6. PMID: 16091446.
    Citations: 23     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
  98. Korzenik JR, Dieckgraefe BK, Valentine JF, Hausman DF, Gilbert MJ. Sargramostim for active Crohn's disease. N Engl J Med. 2005 May 26; 352(21):2193-201. PMID: 15917384.
    Citations: 87     Fields:    Translation:HumansCTClinical Trials
  99. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005 Apr; 39(4 Suppl 2):S59-65. PMID: 15758661.
    Citations: 24     Fields:    Translation:HumansCells
  100. Korzenik JR, Dieckgraefe BK. An open-labelled study of granulocyte colony-stimulating factor in the treatment of active Crohn's disease. Aliment Pharmacol Ther. 2005 Feb 15; 21(4):391-400. PMID: 15709989.
    Citations: 24     Fields:    Translation:HumansCTClinical Trials
  101. Korzenik JR. Crohn's disease: future anti-tumor necrosis factor therapies beyond infliximab. Gastroenterol Clin North Am. 2004 Jun; 33(2):285-301, ix. PMID: 15177539.
    Citations: 3     Fields:    Translation:Humans
  102. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, Fedorak RN, Kamm MA, Korzenik JR, Lashner BA, Onken JE, Rachmilewitz D, Rutgeerts P, Wild G, Wolf DC, Marsters PA, Travers SB, Blank MA, van Deventer SJ. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med. 2004 Feb 26; 350(9):876-85. PMID: 14985485.
    Citations: 342     Fields:    Translation:HumansCTClinical Trials
  103. Dieckgraefe BK, Korzenik JR. Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet. 2002 Nov 09; 360(9344):1478-80. PMID: 12433518.
    Citations: 48     Fields:    Translation:HumansCTClinical Trials
  104. Dieckgraefe BK, Korzenik JR, Husain A, Dieruf L. Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr. 2002 Oct; 161 Suppl 1:S88-92. PMID: 12373579.
    Citations: 26     Fields:    Translation:Humans
  105. Krishnan A, Korzenik JR. Inflammatory bowel disease and environmental influences. Gastroenterol Clin North Am. 2002 Mar; 31(1):21-39. PMID: 12122733.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  106. Dieckgraefe BK, Stenson WF, Korzenik JR, Swanson PE, Harrington CA. Analysis of mucosal gene expression in inflammatory bowel disease by parallel oligonucleotide arrays. Physiol Genomics. 2000 Nov 09; 4(1):1-11. PMID: 11074008.
    Citations: 60     Fields:    Translation:HumansCells
  107. Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, Pollak JS, White RI. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2000 Sep 28; 343(13):931-6. PMID: 11006369.
    Citations: 51     Fields:    Translation:Humans
  108. Whiting JH, Korzenik JR, Miller FJ, Pollack JS, White RI. Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol. 2000 Jul-Aug; 11(7):855-8. PMID: 10928521.
    Citations: 7     Fields:    Translation:HumansCells
  109. Korzenik JR, Dieckgraefe BK. Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease. Dig Dis Sci. 2000 Jun; 45(6):1121-9. PMID: 10877227.
    Citations: 26     Fields:    Translation:HumansCells
  110. Korzenik JR. Infliximab for fistulas: a hole in one? Inflamm Bowel Dis. 2000 Feb; 6(1):62-3. PMID: 10701153.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  111. Miller FJ, Whiting JH, Korzenik JR, White RI. Caution with use of hepatic embolization in the treatment of hereditary hemorrhagic telangiectasia. Radiology. 1999 Dec; 213(3):928-30. PMID: 10580979.
    Citations: 3     Fields:    Translation:Humans
  112. Krinsky ML, Robert ME, Garcia JC, Korzenik JR, Topazian M. Polypoid vascular malformations of the small intestine. Gastrointest Endosc. 1998 Nov; 48(5):530-3. PMID: 9831847.
    Citations: 1     Fields:    Translation:Humans
  113. Lee JY, Korzenik JR, DeMasi R, Lih-Brody L, White RI. Transjugular intrahepatic portosystemic shunts in patients with hereditary hemorrhagic telangiectasia: failure to palliate gastrointestinal bleeding. J Vasc Interv Radiol. 1998 Nov-Dec; 9(6):994-7. PMID: 9840048.
    Citations:    Fields:    Translation:Humans
  114. Korzenik JR, Hsu A, Robert ME. Effect of heparin on dextran sulfate sodium-induced colitis. Dig Dis Sci. 1998 Aug; 43(8):1800-5. PMID: 9724172.
    Citations: 4     Fields:    Translation:Animals
  115. Ullman T, Korzenik JR. Yogurt as oral bacteriotherapy for diarrhea: back to the future? Indian Pediatr. 1998 Jun; 35(6):503-6. PMID: 10216643.
    Citations:    Fields:    Translation:Humans
  116. Husain A, Korzenik JR. Nutritional issues and therapy in inflammatory bowel disease. Semin Gastrointest Dis. 1998 Jan; 9(1):21-30. PMID: 9547853.
    Citations: 4     Fields:    Translation:Humans
  117. Saito K, Korzenik JR, Jekel JF, Bhattacharji S. A case-control study of maternal knowledge of malnutrition and health-care-seeking attitudes in rural South India. Yale J Biol Med. 1997 Mar-Apr; 70(2):149-60. PMID: 9493847.
    Citations: 8     Fields:    Translation:Humans
  118. Korzenik JR. IBD: A Vascular Disorder? The Case for Heparin Therapy. Inflamm Bowel Dis. 1997; 3(2):87-94. PMID: 23282750.
    Citations: 3     Fields:    
  119. Korzenik JR. Hereditary hemorrhagic telangiectasia and other intestinal vascular anomalies. Gastroenterologist. 1996 Sep; 4(3):203-10. PMID: 8891684.
    Citations: 4     Fields:    Translation:Humans
  120. Korzenik JR, Topazian MD, White R. Treatment of bleeding in hereditary hemorrhagic telangiectasia with aminocaproic acid. N Engl J Med. 1994 Nov 03; 331(18):1236. PMID: 7935675.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Korzenik's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (507)
Explore
_
Co-Authors (89)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.